PTC
TEVA icon

Private Trust Company’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Private Trust Company’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.91K Hold
145
– – ﹤0.01% 2289
2026
Q1 		$4.37K Hold
145
– – ﹤0.01% 2228
2025
Q4 		$4.53K Sell
145
-7
-5% -$172 ﹤0.01% 2187
2025
Q3 		$3.07K Buy
+152
New +$2.67K ﹤0.01% 2271
2024
Q3 		– Sell
-65
Closed -$1.06K – 2351
2024
Q2 		$1.06K Buy
+65
New +$1K ﹤0.01% 2198
2023
Q1 		– Sell
-300
Closed -$3K – 2364
2022
Q4 		$3K Sell
300
-4,000
-93% -$34.9K ﹤0.01% 1967
2022
Q3 		$35K Hold
4,300
– – 0.01% 1020
2022
Q2 		$32K Buy
+4,300
New +$37.5K 0.01% 1079
2016
Q1 		– Sell
-5,427
Closed -$356K – 323
2015
Q4 		$356K Buy
5,427
+1,876
+53% +$116K 0.1% 220
2015
Q3 		$200K Sell
3,551
-828
-19% -$53.7K 0.06% 302
2015
Q2 		$258K Buy
4,379
+401
+10% +$24.7K 0.07% 269
2015
Q1 		$247K Sell
3,978
-344
-8% -$20K 0.07% 281
2014
Q4 		$248K Buy
4,322
+186
+4% +$10.4K 0.08% 252
2014
Q3 		$222K Buy
4,136
+9
+0.2% +$477 0.08% 264
2014
Q2 		$216K Buy
4,127
+381
+10% +$19.5K 0.07% 278
2014
Q1 		$198K Sell
3,746
-168
-4% -$7.76K 0.07% 251
2013
Q4 		$157K Buy
3,914
+247
+7% +$9.73K 0.06% 250
2013
Q3 		$139K Buy
3,667
+309
+9% +$12.1K 0.06% 254
2013
Q2 		$132K Buy
+3,358
New +$131K 0.06% 245

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Private Trust Company's TEVA Position: Q2 2026 in Review

Private Trust Company held its Teva Pharmaceutical Industries Limited (TEVA) position steady in Q2 2026 at 145 shares worth $4.91K. The position accounts for ﹤0.01% of the portfolio, ranked #2289.

Private Trust Company first reported a position in TEVA in Q2 2013 and has held it in 19 quarters since. The position peaked at $356K in Q4 2015. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Private Trust Company held 145 shares of Teva Pharmaceutical Industries Limited worth $4.91K as of Q2 2026.
  • Private Trust Company left its Teva Pharmaceutical Industries Limited share count unchanged in Q2 2026.
  • Teva Pharmaceutical Industries Limited made up ﹤0.01% of Private Trust Company's portfolio in Q2 2026, its #2289 holding.
  • Private Trust Company first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and has held it in 19 quarters since.
  • Private Trust Company's Teva Pharmaceutical Industries Limited position peaked at $356K in Q4 2015.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Private Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.